Poly(ethyl glyoxylate)-Poly(ethylene oxide) Nanoparticles: Stimuli-Responsive Drug Release via End-to-End Polyglyoxylate Depolymerization

The ability to disrupt polymer assemblies in response to specific stimuli provides the potential to release drugs selectively at certain sites or conditions in vivo. However, most stimuli-responsive delivery systems require many stimuli-initiated events to release drugs. “Self-immolative polymers” o...

Full description

Saved in:
Bibliographic Details
Published inMolecular pharmaceutics Vol. 14; no. 8; pp. 2548 - 2559
Main Authors Fan, Bo, Gillies, Elizabeth R
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 07.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The ability to disrupt polymer assemblies in response to specific stimuli provides the potential to release drugs selectively at certain sites or conditions in vivo. However, most stimuli-responsive delivery systems require many stimuli-initiated events to release drugs. “Self-immolative polymers” offer the potential to provide amplified responses to stimuli as they undergo complete end-to-end depolymerization following the cleavage of a single end-cap. Herein, linker end-caps were developed to conjugate self-immolative poly­(ethyl glyoxylate) (PEtG) with poly­(ethylene oxide) (PEO) to form amphiphilic block copolymers. These copolymers were self-assembled to form nanoparticles in aqueous solution. Cleavage of the linker end-caps were triggered by a thiol reducing agent, UV light, H2O2, and combinations of these stimuli, resulting in nanoparticle disintegration. Low stimuli concentrations were effective in rapidly disrupting the nanoparticles. Nile red, doxorubin, and curcumin were encapsulated into the nanoparticles and were selectively released upon application of the appropriate stimulus. The ability to tune the stimuli-responsiveness simply by changing the linker end-cap makes this new platform highly attractive for applications in drug delivery.
AbstractList The ability to disrupt polymer assemblies in response to specific stimuli provides the potential to release drugs selectively at certain sites or conditions in vivo. However, most stimuli-responsive delivery systems require many stimuli-initiated events to release drugs. "Self-immolative polymers" offer the potential to provide amplified responses to stimuli as they undergo complete end-to-end depolymerization following the cleavage of a single end-cap. Herein, linker end-caps were developed to conjugate self-immolative poly(ethyl glyoxylate) (PEtG) with poly(ethylene oxide) (PEO) to form amphiphilic block copolymers. These copolymers were self-assembled to form nanoparticles in aqueous solution. Cleavage of the linker end-caps were triggered by a thiol reducing agent, UV light, H O , and combinations of these stimuli, resulting in nanoparticle disintegration. Low stimuli concentrations were effective in rapidly disrupting the nanoparticles. Nile red, doxorubin, and curcumin were encapsulated into the nanoparticles and were selectively released upon application of the appropriate stimulus. The ability to tune the stimuli-responsiveness simply by changing the linker end-cap makes this new platform highly attractive for applications in drug delivery.
The ability to disrupt polymer assemblies in response to specific stimuli provides the potential to release drugs selectively at certain sites or conditions in vivo. However, most stimuli-responsive delivery systems require many stimuli-initiated events to release drugs. "Self-immolative polymers" offer the potential to provide amplified responses to stimuli as they undergo complete end-to-end depolymerization following the cleavage of a single end-cap. Herein, linker end-caps were developed to conjugate self-immolative poly(ethyl glyoxylate) (PEtG) with poly(ethylene oxide) (PEO) to form amphiphilic block copolymers. These copolymers were self-assembled to form nanoparticles in aqueous solution. Cleavage of the linker end-caps were triggered by a thiol reducing agent, UV light, H2O2, and combinations of these stimuli, resulting in nanoparticle disintegration. Low stimuli concentrations were effective in rapidly disrupting the nanoparticles. Nile red, doxorubin, and curcumin were encapsulated into the nanoparticles and were selectively released upon application of the appropriate stimulus. The ability to tune the stimuli-responsiveness simply by changing the linker end-cap makes this new platform highly attractive for applications in drug delivery.
The ability to disrupt polymer assemblies in response to specific stimuli provides the potential to release drugs selectively at certain sites or conditions in vivo. However, most stimuli-responsive delivery systems require many stimuli-initiated events to release drugs. “Self-immolative polymers” offer the potential to provide amplified responses to stimuli as they undergo complete end-to-end depolymerization following the cleavage of a single end-cap. Herein, linker end-caps were developed to conjugate self-immolative poly­(ethyl glyoxylate) (PEtG) with poly­(ethylene oxide) (PEO) to form amphiphilic block copolymers. These copolymers were self-assembled to form nanoparticles in aqueous solution. Cleavage of the linker end-caps were triggered by a thiol reducing agent, UV light, H2O2, and combinations of these stimuli, resulting in nanoparticle disintegration. Low stimuli concentrations were effective in rapidly disrupting the nanoparticles. Nile red, doxorubin, and curcumin were encapsulated into the nanoparticles and were selectively released upon application of the appropriate stimulus. The ability to tune the stimuli-responsiveness simply by changing the linker end-cap makes this new platform highly attractive for applications in drug delivery.
Author Fan, Bo
Gillies, Elizabeth R
AuthorAffiliation Department of Chemistry
Department of Chemical and Biochemical Engineering
The University of Western Ontario
AuthorAffiliation_xml – name: The University of Western Ontario
– name: Department of Chemical and Biochemical Engineering
– name: Department of Chemistry
Author_xml – sequence: 1
  givenname: Bo
  surname: Fan
  fullname: Fan, Bo
  organization: The University of Western Ontario
– sequence: 2
  givenname: Elizabeth R
  orcidid: 0000-0002-3983-2248
  surname: Gillies
  fullname: Gillies, Elizabeth R
  email: egillie@uwo.ca
  organization: The University of Western Ontario
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28294625$$D View this record in MEDLINE/PubMed
BookMark eNqNUctu2zAQJIoUdV6_ULC35CCHpCiT6q1I0iZA0AZ5nAWKWtk0KFIlqSDKH_SvK8NOgt562sVgdgazc4D2nHeA0BdK5pQweqZ0nHfe9isVOqVhSHNRE0Jy8gHt04LnmcxLtve2Sz5DBzGuCWG8YPknNGOSlXzBin3059bb8QTSarR4aUf_PFqV4DR7h8EB9s-mgVP8Uznfq5CMthC_4vtkusGa7A5i7100T4AvwrDEd2BBRcBPRuFL12TJZ9PAG8l3C3wB_QR0EMyLSsa7I_SxVTbC8W4eosfvlw_nV9nNrx_X599uMsUpTxlvWCtIO0XhlJQgFwS4BqGKhpWSk7rmVLRAClG2mpa1ahq9kFRRojkRrCnyQ3Sy1e2D_z1ATFVnogZrlQM_xIpKIWTBhCwnarml6uBjDNBWfTCdCmNFSbVpopqaqP5poto1Md1-3tkMdQfN2-Xr6ydCsSVsNNZ-CG5K_R_CfwFLbKHT
CitedBy_id crossref_primary_10_1002_cptc_201900166
crossref_primary_10_1021_acs_macromol_9b00965
crossref_primary_10_1021_acsomega_8b00534
crossref_primary_10_3390_nano11041028
crossref_primary_10_1039_D1NA00120E
crossref_primary_10_1021_acs_chemrev_3c00705
crossref_primary_10_1021_jacs_9b05560
crossref_primary_10_1002_anie_202318881
crossref_primary_10_1021_acsabm_1c00351
crossref_primary_10_1039_C7CC06410A
crossref_primary_10_1021_acsmacrolett_0c00865
crossref_primary_10_1016_j_polymer_2020_122638
crossref_primary_10_1039_D0PY00461H
crossref_primary_10_1021_acs_biomac_1c00694
crossref_primary_10_1039_D1PY00257K
crossref_primary_10_1039_D0TB01119C
crossref_primary_10_1039_D2PY00240J
crossref_primary_10_1021_acsnano_0c09166
crossref_primary_10_1038_s41467_022_32609_1
crossref_primary_10_1039_D1BM01684A
crossref_primary_10_1016_j_giant_2020_100012
crossref_primary_10_1021_acsnano_3c01117
crossref_primary_10_1021_acs_biomac_3c00630
crossref_primary_10_1016_j_progpolymsci_2019_101164
crossref_primary_10_1021_acs_macromol_2c00615
crossref_primary_10_1039_D1PY01169C
crossref_primary_10_1039_D2PY00414C
crossref_primary_10_1039_D2PY00701K
crossref_primary_10_1021_acs_macromol_1c01003
crossref_primary_10_1021_acsnano_1c05089
crossref_primary_10_1016_j_cobme_2022_100437
crossref_primary_10_1021_acs_macromol_1c01796
crossref_primary_10_1002_adtp_201800030
crossref_primary_10_1016_j_bioorg_2019_01_019
crossref_primary_10_1021_acsapm_2c00542
crossref_primary_10_1039_C8PY00350E
crossref_primary_10_1021_acs_biomac_1c01165
crossref_primary_10_1002_pola_29070
crossref_primary_10_1016_j_apsb_2021_03_033
crossref_primary_10_1002_slct_202000423
crossref_primary_10_1016_j_jddst_2023_105011
crossref_primary_10_1021_acspolymersau_2c00013
crossref_primary_10_1021_acs_chemmater_9b01798
crossref_primary_10_1021_acs_jafc_9b04717
crossref_primary_10_1021_acs_macromol_2c01528
crossref_primary_10_1021_acs_biomac_3c00382
crossref_primary_10_1021_acs_macromol_0c01197
crossref_primary_10_1002_ange_202318881
crossref_primary_10_1002_marc_201800917
crossref_primary_10_1016_j_cej_2017_12_098
crossref_primary_10_1021_acs_macromol_0c00861
crossref_primary_10_1021_acs_biomac_0c00899
crossref_primary_10_1021_acs_macromol_8b02616
crossref_primary_10_3390_pharmaceutics14020421
crossref_primary_10_1021_acs_macromol_8b01007
Cites_doi 10.1002/anie.201506511
10.1039/C5PY00257E
10.1021/ja905343x
10.1021/ma4007413
10.1021/ja00485a032
10.1021/acs.macromol.6b02320
10.1021/ja104420k
10.3390/molecules191220091
10.1016/j.ajps.2013.07.021
10.1038/nrm2240
10.1158/0008-5472.CAN-12-4561
10.1073/pnas.89.17.7944
10.1021/ac061578f
10.1002/wnan.1332
10.1016/j.addr.2012.10.002
10.1002/pola.24180
10.1016/j.redox.2013.10.005
10.1039/c2cs35115c
10.1021/bm900074d
10.1007/s10924-012-0429-2
10.1126/science.1074972
10.1021/jp984620m
10.1039/c1cc13583j
10.1016/j.progpolymsci.2010.06.002
10.1083/jcb.100.3.965
10.1016/j.addr.2012.09.026
10.1039/C2TB00063F
10.1021/jacs.5b05060
10.1016/j.jconrel.2011.01.030
10.1111/j.2042-7158.2012.01567.x
10.1016/j.progpolymsci.2010.06.003
10.1016/j.jconrel.2007.12.017
10.1021/ja504727u
10.1021/mz3002403
10.1021/acs.macromol.6b01620
10.2174/1389200023337388
10.1021/ja303372u
10.1021/ac402415v
10.1016/j.addr.2011.09.012
10.1039/c3cs35469e
10.1039/c3ra46396f
10.1038/cddis.2011.96
10.1021/ja5030832
10.1021/ja801065d
10.1021/ja803947s
10.1021/mz5000784
10.1002/0471440264.pst610
10.1152/ajpcell.00238.2004
10.1016/S1369-7021(10)70106-1
10.1002/macp.201300023
10.1016/j.biotechadv.2013.11.009
10.1039/B304251K
10.2165/00003088-200140070-00005
10.1155/2012/103973
10.1016/j.abb.2016.05.005
10.1039/C2CS35265F
ContentType Journal Article
Copyright Copyright © 2017 American Chemical Society
Copyright_xml – notice: Copyright © 2017 American Chemical Society
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1021/acs.molpharmaceut.7b00030
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1543-8392
EndPage 2559
ExternalDocumentID 10_1021_acs_molpharmaceut_7b00030
28294625
b390380237
Genre Journal Article
GroupedDBID -
123
53G
55A
7~N
AABXI
ABMVS
ABUCX
ACGFS
ACS
AEESW
AENEX
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
CS3
DU5
EBS
ED
ED~
EJD
F5P
GNL
H~9
IH9
JG
JG~
P2P
RNS
ROL
UI2
VF5
VG9
W1F
X
---
-~X
4.4
5VS
ABJNI
ABQRX
ADHLV
AHGAQ
BAANH
CGR
CUPRZ
CUY
CVF
ECM
EIF
GGK
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-a414t-4d2f70f0244109e860e4ce7a5d29840bb417fe0579fc19baddc681a10c4072d53
IEDL.DBID ACS
ISSN 1543-8384
IngestDate Fri Aug 16 22:44:28 EDT 2024
Fri Dec 06 05:11:00 EST 2024
Wed Oct 16 00:58:17 EDT 2024
Thu Aug 27 13:43:10 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords self-immolative
drug delivery
depolymerization
stimuli-responsive
polyglyoxylate
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a414t-4d2f70f0244109e860e4ce7a5d29840bb417fe0579fc19baddc681a10c4072d53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3983-2248
OpenAccessLink https://ir.lib.uwo.ca/cgi/viewcontent.cgi?article=1100&context=chempub
PMID 28294625
PQID 1877852789
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_1877852789
crossref_primary_10_1021_acs_molpharmaceut_7b00030
pubmed_primary_28294625
acs_journals_10_1021_acs_molpharmaceut_7b00030
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
VG9
W1F
ACS
AEESW
AFEFF
ABMVS
ABUCX
IH9
AQSVZ
ED~
UI2
PublicationCentury 2000
PublicationDate 2017-08-07
PublicationDateYYYYMMDD 2017-08-07
PublicationDate_xml – month: 08
  year: 2017
  text: 2017-08-07
  day: 07
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Molecular pharmaceutics
PublicationTitleAlternate Mol. Pharmaceutics
PublicationYear 2017
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref45/cit45
ref3/cit3
ref27/cit27
ref56/cit56
ref16/cit16
ref52/cit52
ref23/cit23
ref8/cit8
ref31/cit31
ref2/cit2
ref34/cit34
ref37/cit37
ref20/cit20
ref48/cit48
ref17/cit17
ref10/cit10
ref35/cit35
ref53/cit53
ref19/cit19
ref21/cit21
ref42/cit42
ref46/cit46
ref49/cit49
ref13/cit13
ref24/cit24
ref38/cit38
ref50/cit50
ref54/cit54
ref6/cit6
ref36/cit36
ref18/cit18
ref11/cit11
ref25/cit25
ref29/cit29
ref32/cit32
ref39/cit39
ref14/cit14
ref57/cit57
ref5/cit5
ref51/cit51
ref43/cit43
ref28/cit28
ref26/cit26
ref55/cit55
ref12/cit12
ref15/cit15
Kuppusamy P. (ref40/cit40) 2002; 62
ref41/cit41
ref22/cit22
ref33/cit33
ref4/cit4
ref30/cit30
ref47/cit47
ref1/cit1
ref44/cit44
ref7/cit7
References_xml – ident: ref32/cit32
  doi: 10.1002/anie.201506511
– ident: ref17/cit17
  doi: 10.1039/C5PY00257E
– ident: ref34/cit34
  doi: 10.1021/ja905343x
– ident: ref26/cit26
  doi: 10.1021/ma4007413
– ident: ref50/cit50
  doi: 10.1021/ja00485a032
– ident: ref28/cit28
  doi: 10.1021/acs.macromol.6b02320
– ident: ref31/cit31
  doi: 10.1021/ja104420k
– ident: ref57/cit57
  doi: 10.3390/molecules191220091
– ident: ref12/cit12
  doi: 10.1016/j.ajps.2013.07.021
– ident: ref51/cit51
  doi: 10.1038/nrm2240
– ident: ref7/cit7
  doi: 10.1158/0008-5472.CAN-12-4561
– ident: ref49/cit49
  doi: 10.1073/pnas.89.17.7944
– ident: ref39/cit39
  doi: 10.1021/ac061578f
– ident: ref6/cit6
  doi: 10.1002/wnan.1332
– ident: ref8/cit8
  doi: 10.1016/j.addr.2012.10.002
– ident: ref27/cit27
  doi: 10.1002/pola.24180
– ident: ref48/cit48
  doi: 10.1016/j.redox.2013.10.005
– ident: ref1/cit1
  doi: 10.1039/c2cs35115c
– ident: ref11/cit11
  doi: 10.1021/bm900074d
– ident: ref37/cit37
  doi: 10.1007/s10924-012-0429-2
– ident: ref46/cit46
  doi: 10.1126/science.1074972
– ident: ref54/cit54
  doi: 10.1021/jp984620m
– ident: ref43/cit43
  doi: 10.1039/c1cc13583j
– ident: ref2/cit2
  doi: 10.1016/j.progpolymsci.2010.06.002
– ident: ref53/cit53
  doi: 10.1083/jcb.100.3.965
– ident: ref5/cit5
  doi: 10.1016/j.addr.2012.09.026
– ident: ref16/cit16
  doi: 10.1039/C2TB00063F
– ident: ref30/cit30
  doi: 10.1021/jacs.5b05060
– ident: ref15/cit15
  doi: 10.1016/j.jconrel.2011.01.030
– ident: ref55/cit55
  doi: 10.1111/j.2042-7158.2012.01567.x
– ident: ref4/cit4
  doi: 10.1016/j.progpolymsci.2010.06.003
– ident: ref14/cit14
  doi: 10.1016/j.jconrel.2007.12.017
– ident: ref22/cit22
  doi: 10.1021/ja504727u
– ident: ref23/cit23
  doi: 10.1021/mz3002403
– ident: ref33/cit33
  doi: 10.1021/acs.macromol.6b01620
– ident: ref35/cit35
  doi: 10.2174/1389200023337388
– ident: ref18/cit18
  doi: 10.1021/ja303372u
– ident: ref25/cit25
  doi: 10.1021/ac402415v
– ident: ref21/cit21
  doi: 10.1016/j.addr.2011.09.012
– ident: ref42/cit42
  doi: 10.1039/c3cs35469e
– ident: ref56/cit56
  doi: 10.1039/c3ra46396f
– ident: ref41/cit41
  doi: 10.1038/cddis.2011.96
– ident: ref24/cit24
  doi: 10.1021/ja5030832
– ident: ref29/cit29
  doi: 10.1021/ja801065d
– ident: ref10/cit10
  doi: 10.1021/ja803947s
– ident: ref19/cit19
  doi: 10.1021/mz5000784
– ident: ref20/cit20
  doi: 10.1002/0471440264.pst610
– ident: ref36/cit36
  doi: 10.1152/ajpcell.00238.2004
– ident: ref3/cit3
  doi: 10.1016/S1369-7021(10)70106-1
– ident: ref38/cit38
  doi: 10.1002/macp.201300023
– ident: ref13/cit13
  doi: 10.1016/j.biotechadv.2013.11.009
– volume: 62
  start-page: 307
  year: 2002
  ident: ref40/cit40
  publication-title: Cancer Res.
  contributor:
    fullname: Kuppusamy P.
– ident: ref47/cit47
  doi: 10.1039/B304251K
– ident: ref44/cit44
  doi: 10.2165/00003088-200140070-00005
– ident: ref45/cit45
  doi: 10.1155/2012/103973
– ident: ref52/cit52
  doi: 10.1016/j.abb.2016.05.005
– ident: ref9/cit9
  doi: 10.1039/C2CS35265F
SSID ssj0024523
Score 2.470838
Snippet The ability to disrupt polymer assemblies in response to specific stimuli provides the potential to release drugs selectively at certain sites or conditions in...
SourceID proquest
crossref
pubmed
acs
SourceType Aggregation Database
Index Database
Publisher
StartPage 2548
SubjectTerms Curcumin - chemistry
Drug Carriers - chemistry
Drug Delivery Systems - methods
Drug Liberation
Hydrogen Peroxide - chemistry
Methylmethacrylates - chemistry
Nanoparticles - chemistry
Polyethylene Glycols - chemistry
Title Poly(ethyl glyoxylate)-Poly(ethylene oxide) Nanoparticles: Stimuli-Responsive Drug Release via End-to-End Polyglyoxylate Depolymerization
URI http://dx.doi.org/10.1021/acs.molpharmaceut.7b00030
https://www.ncbi.nlm.nih.gov/pubmed/28294625
https://search.proquest.com/docview/1877852789
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS91AEB6sQumLvdjWU9uygkgF9zSXTXbTt-IF6YMc9Ai-hb1FDsakmBxp_Af-a2eTnAYrpfUpsCSzm92ZnW92LguwFcQGUUbkBClUlNkwo0p4llobh5xnWoeqDZA9jo_O2I_z6HzI4_7Tgx_4X6WuxlelSzztj3jHvEPyz2Al4GiGOzy0dzoU2IvaO90QGoRUhII9h81_knKqSVcPVdNf8Gardw5fwnSRvdOFm1yO57Ua69vHxRyf8kuvYLXHoeR7xzivYckWb2B70r3b7JLpkJdV7ZJtMhlKXDdrcDcp8-aLxUXOyUXe4NByxKw7dGjGLZSUv2bG7hDcwNEy7wPwvpHTeuZCsuhJH517Y8n-9fyCnKACRJVKbmaSHBSG1iXFB3Ekhy7IPhoMeePcTF3-6Fs4OzyY7h3R_lIHKpnPaspMkHEvw3VivpdYEXuWactlZIIEjU2lmM8z61JkM-0nCrdfHQtf-p52pdxMFL6D5aIs7DqQTCqjEi3RCouZ0YkSLEMykUlk7IUiHgHyZJX2Qlmlrb898FPX-GD60376RxAsGCD92RX7-J-PNheskqJoOn-LLGw5x_4E5yJyqcYjeN_x0G-yzoHN0Pb88NQxbsCLwCELF7XCP8JyfT23nxAX1epzKwf3GQYQDA
link.rule.ids 314,780,784,2765,27076,27924,27925,56738,56788
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB60gvpivXusly1IsdA95rLJbnyTXjhqLYf2FAp9CNnNphyMiTQ5pek_8F87k6QNFcTLU2BJJpPdmZ1vMpcFeOOFKaKMgBTJ11xYP-NaOZZbG_pSZsb4uk2Q3Qsnh-LTUXDUZ1VSLQwyUSGlqg3iD90F3Hc09q2k-tP-T-9YdoD-JtwK6OhKgkWbB0OfvaA92g0Rgs-Vr8RtWP0jKbJQprpuoX4DO1vzs7MMx1eMt1knX8eLWo_NxS89Hf_vy-7DvR6Vsg-dGD2AG7Z4CGvT7t5mg82GKq1qg62x6dDwunkEP6Zl3ry1uOQ5O8kb5DBHBLvOh2HcUFl5Pk_tOsPtHP30Ph3vPTuo55Sgxff7XN0zy7ZOFydsH80hGlh2Nk_YdpHyuuR4YURyeAXbQvchbyjo1FWTPobDne3Z5oT3RzzwRLii5iL1MulkuFzCdSKrQscKY2USpF6ErqfWwpWZpYLZzLiRxs3YhMpNXMdQY7c08J_AUlEW9hmwLNGpjkyCPlkoUhNpJTIkE6RREjq-CkdAsx_3KlrFbfTdc2MavDb9cT_9I_Au5SD-3rX--JuHVi8lJkZFpehLUthyge9TUqqACo9H8LQTpSuyFM4W6Ik-_1ceX8OdyezLbrz7ce_zCtz1CHNQPot8AUv16cK-RMRU61etavwEgesYeQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1pS9xAdGgtSL_U3l3tMUKRCs42xySZ9Ju4LvZAFg_wW8hcshgTMVkx_Qf9130vGQ0WSo9PgSF58zLzznnHEPI-iDVYGREyUigZN6FlUniGGROHSWKVCmWXILsf7x3zLyfRiTtww1oYQKIGSHUXxEeuvtDWdRjwP-L4eYU1qO60d5z0Rv198iACqYspXds7h0Ovvai73g2shJCJUPBlsv5HUKilVH1XS_3G9OxU0HSFZLfId5knZ-NFI8fq-y99Hf__7x6TR846pds9OT0h90z5lGzM-nfbLXo0VGvVW3SDzobG1-0z8mNWFe0HA1tf0NOiBSwLsGQ32TAMgpVW13NtNimIdfDXXVreJ3rYzDFRix24nN0rQyeXi1N6AGoRFC29mud0t9SsqRg8KIIcpqATcCOKFoNPfVXpc3I83T3a2WPuqgeWc583jOvAJp6FLeO-lxoRe4Yrk-SRDlJwQaXkfmINFs5a5acShLKKhZ_7nsIGbzoKX5ClsirNK0JtLrVMVQ6-Wcy1SqXgFsBEOs1jLxTxiOAOZI5V66yLwgd-hoN3lj9zyz8iwQ0tZBd9C5C_-Wj9hmoyYFiMwuSlqRYwn0gSEWEB8oi87MnpFiyGtTl4pKv_iuM7sjybTLNvn_e_rpGHAZoemNaSvCZLzeXCvAHDqZFvO-74CUlpGvw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Poly%28ethyl+glyoxylate%29-Poly%28ethylene+oxide%29+Nanoparticles%3A+Stimuli-Responsive+Drug+Release+via+End-to-End+Polyglyoxylate+Depolymerization&rft.jtitle=Molecular+pharmaceutics&rft.au=Fan%2C+Bo&rft.au=Gillies%2C+Elizabeth+R&rft.date=2017-08-07&rft.eissn=1543-8392&rft.volume=14&rft.issue=8&rft.spage=2548&rft.epage=2559&rft_id=info:doi/10.1021%2Facs.molpharmaceut.7b00030&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1543-8384&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1543-8384&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1543-8384&client=summon